Menü
sharewise zieht um Am Wochenende vom 22./23. August wird das neue sharewise die Hauptseite. Schau es dir jetzt an und sag uns, was dir fehlt. Zum neuen sharewise Was sich ändert
Microsoft selbst warnt vor der Verwendung von Internet Explorer, da er nicht mehr den neuesten Web- und Sicherheitsstandards entspricht. Wir können daher nicht garantieren, dass die Seite im Internet Explorer in vollem Umfang funktioniert. Nutze bitte Chrome oder Firefox.

Blog

Vertex Pharmaceuticals (VRTX) Expected to Beat Earnings Estimates: What to Know Ahead of Q1 ReleasePhoto, wide shot, wide-angle lens,  Clinical research organization, Blue hour, twilight, cool, ISO1200, slow shutter speed, photo by Michael Light: https://img.theapi.app/temp/c28f6640-54ba-4d2b-afbe-b5fd3b0ee19e.png
Vertex Pharmaceuticals (VRTX) Expected to Beat Earnings Estimates: What to Know Ahead of Q1 Release

The market expects Vertex Pharmaceuticals (VRTX) to deliver a year-over-year decline in earnings on higher revenues when it reports results for the quarter ended March 2025. This widely-known

Analysts Estimate Freshpet (FRPT) to Report a Decline in Earnings: What to Look Out for
Analysts Estimate Freshpet (FRPT) to Report a Decline in Earnings: What to Look Out for

Wall Street expects a year-over-year decline in earnings on higher revenues when Freshpet (FRPT) reports results for the quarter ended March 2025. While this widely-known consensus outlook is

Henry Schein (HSIC) Reports Next Week: Wall Street Expects Earnings Growth
Henry Schein (HSIC) Reports Next Week: Wall Street Expects Earnings Growth

Wall Street expects a year-over-year increase in earnings on higher revenues when Henry Schein (HSIC) reports results for the quarter ended March 2025. While this widely-known consensus outlook is

Earnings Preview: Interparfums (IPAR) Q1 Earnings Expected to Decline
Earnings Preview: Interparfums (IPAR) Q1 Earnings Expected to Decline

Wall Street expects a year-over-year decline in earnings on higher revenues when Interparfums (IPAR) reports results for the quarter ended March 2025. While this widely-known consensus outlook is

Hims & Hers Health, Inc. (HIMS) Earnings Expected to Grow: Should You Buy?
Hims & Hers Health, Inc. (HIMS) Earnings Expected to Grow: Should You Buy?

Hims & Hers Health, Inc. (HIMS) is expected to deliver a year-over-year increase in earnings on higher revenues when it reports results for the quarter ended March 2025. This widely-known consensus

Coterra Energy (CTRA) Earnings Expected to Grow: What to Know Ahead of Next Week's Release
Coterra Energy (CTRA) Earnings Expected to Grow: What to Know Ahead of Next Week's Release

The market expects Coterra Energy (CTRA) to deliver a year-over-year increase in earnings on higher revenues when it reports results for the quarter ended March 2025. This widely-known consensus

Diamondback Energy (FANG) Expected to Beat Earnings Estimates: Can the Stock Move Higher?
Diamondback Energy (FANG) Expected to Beat Earnings Estimates: Can the Stock Move Higher?

The market expects Diamondback Energy (FANG) to deliver a year-over-year decline in earnings on higher revenues when it reports results for the quarter ended March 2025. This widely-known consensus

Certara, Inc. (CERT) Earnings Expected to Grow: Should You Buy?
Certara, Inc. (CERT) Earnings Expected to Grow: Should You Buy?

Certara, Inc. (CERT) is expected to deliver a year-over-year increase in earnings on higher revenues when it reports results for the quarter ended March 2025. This widely-known consensus outlook

Analysts Estimate BWX Technologies (BWXT) to Report a Decline in Earnings: What to Look Out for
Analysts Estimate BWX Technologies (BWXT) to Report a Decline in Earnings: What to Look Out for

The market expects BWX Technologies (BWXT) to deliver a year-over-year decline in earnings on higher revenues when it reports results for the quarter ended March 2025. This widely-known consensus

Corebridge Financial (CRBG) Earnings Expected to Grow: Should You Buy?
Corebridge Financial (CRBG) Earnings Expected to Grow: Should You Buy?

Corebridge Financial (CRBG) is expected to deliver a year-over-year increase in earnings on lower revenues when it reports results for the quarter ended March 2025. This widely-known consensus

Analysts Estimate Crescent Energy (CRGY) to Report a Decline in Earnings: What to Look Out for
Analysts Estimate Crescent Energy (CRGY) to Report a Decline in Earnings: What to Look Out for

Wall Street expects a year-over-year decline in earnings on higher revenues when Crescent Energy (CRGY) reports results for the quarter ended March 2025. While this widely-known consensus outlook is

BellRing Brands (BRBR) Earnings Expected to Grow: What to Know Ahead of Next Week's Release
BellRing Brands (BRBR) Earnings Expected to Grow: What to Know Ahead of Next Week's Release

Wall Street expects a year-over-year increase in earnings on higher revenues when BellRing Brands (BRBR) reports results for the quarter ended March 2025. While this widely-known consensus outlook

Freightcar America (RAIL) Earnings Expected to Grow: Should You Buy?
Freightcar America (RAIL) Earnings Expected to Grow: Should You Buy?

Freightcar America (RAIL) is expected to deliver a year-over-year increase in earnings on lower revenues when it reports results for the quarter ended March 2025. This widely-known consensus outlook

BioCryst Pharmaceuticals (BCRX) May Report Negative Earnings: Know the Trend Ahead of Next Week's ReleasePhoto, wide shot, wide-angle lens,  Biotech company, Blue hour, twilight, cool, ISO1200, slow shutter speed, photo by Sebastião Salgado: https://img.theapi.app/temp/80e18bfd-1ff8-4487-af62-1cdb7de1ceb6.png
BioCryst Pharmaceuticals (BCRX) May Report Negative Earnings: Know the Trend Ahead of Next Week's Release

BioCryst Pharmaceuticals (BCRX) is expected to deliver a year-over-year increase in earnings on higher revenues when it reports results for the quarter ended March 2025. This widely-known consensus

The Beachbody Company, Inc. (BODI) May Report Negative Earnings: Know the Trend Ahead of Q1 Release
The Beachbody Company, Inc. (BODI) May Report Negative Earnings: Know the Trend Ahead of Q1 Release

The market expects The Beachbody Company, Inc. (BODI) to deliver a year-over-year increase in earnings on lower revenues when it reports results for the quarter ended March 2025. This widely-known

Ares Management (ARES) Reports Next Week: Wall Street Expects Earnings Growth
Ares Management (ARES) Reports Next Week: Wall Street Expects Earnings Growth

Wall Street expects a year-over-year increase in earnings on higher revenues when Ares Management (ARES) reports results for the quarter ended March 2025. While this widely-known consensus outlook

Earnings Preview: Axsome Therapeutics (AXSM) Q1 Earnings Expected to Decline
Earnings Preview: Axsome Therapeutics (AXSM) Q1 Earnings Expected to Decline

The market expects Axsome Therapeutics (AXSM) to deliver a year-over-year decline in earnings on higher revenues when it reports results for the quarter ended March 2025. This widely-known consensus

Neurocrine Biosciences (NBIX) Q1 Earnings Preview: What's in the Cards?
Neurocrine Biosciences (NBIX) Q1 Earnings Preview: What's in the Cards?

Wall Street expects flat earnings compared to the year-ago quarter on higher revenues when Neurocrine Biosciences (NBIX) reports results for the quarter ended March 2025. While this widely-known

Primoris Services (PRIM) Earnings Expected to Grow: What to Know Ahead of Next Week's Release
Primoris Services (PRIM) Earnings Expected to Grow: What to Know Ahead of Next Week's Release

Primoris Services (PRIM) is expected to deliver a year-over-year increase in earnings on higher revenues when it reports results for the quarter ended March 2025. This widely-known consensus outlook

Earnings Preview: Williams Companies, Inc. (The) (WMB) Q1 Earnings Expected to Decline
Earnings Preview: Williams Companies, Inc. (The) (WMB) Q1 Earnings Expected to Decline

Williams Companies, Inc. (The) (WMB) is expected to deliver a year-over-year decline in earnings on higher revenues when it reports results for the quarter ended March 2025. This widely-known

ADC Therapeutics SA (ADCT) May Report Negative Earnings: Know the Trend Ahead of Q1 Release
ADC Therapeutics SA (ADCT) May Report Negative Earnings: Know the Trend Ahead of Q1 Release

ADC Therapeutics SA (ADCT) is expected to deliver a year-over-year increase in earnings on higher revenues when it reports results for the quarter ended March 2025. This widely-known consensus

Addus HomeCare (ADUS) Earnings Expected to Grow: Should You Buy?
Addus HomeCare (ADUS) Earnings Expected to Grow: Should You Buy?

The market expects Addus HomeCare (ADUS) to deliver a year-over-year increase in earnings on higher revenues when it reports results for the quarter ended March 2025. This widely-known consensus

Atlas Energy Solutions Inc. (AESI) Expected to Beat Earnings Estimates: What to Know Ahead of Q1 Release
Atlas Energy Solutions Inc. (AESI) Expected to Beat Earnings Estimates: What to Know Ahead of Q1 Release

The market expects Atlas Energy Solutions Inc. (AESI) to deliver a year-over-year decline in earnings on higher revenues when it reports results for the quarter ended March 2025. This widely-known

Analysts Estimate Ameresco (AMRC) to Report a Decline in Earnings: What to Look Out for
Analysts Estimate Ameresco (AMRC) to Report a Decline in Earnings: What to Look Out for

The market expects Ameresco (AMRC) to deliver a year-over-year decline in earnings on higher revenues when it reports results for the quarter ended March 2025. This widely-known consensus outlook is

V2X (VVX) Earnings Expected to Grow: Should You Buy?
V2X (VVX) Earnings Expected to Grow: Should You Buy?

The market expects V2X (VVX) to deliver a year-over-year increase in earnings on higher revenues when it reports results for the quarter ended March 2025. This widely-known consensus outlook is